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SUMMARY – Primary breast lymphoma accounts for 0.04%-0.5% of all breast malignancies. 
Primary non-Hodgkin’s lymphomas of the breast are extremely rare and represent approximately 
0.38%-0.7% of all cases. Epstein-Barr virus (EBV) has been postulated to play an important role in 
the pathogenesis of Hodgkin’s lymphoma. We present a case of EBV-positive primary Hodgkin’s 
lymphoma of the breast. Although there is no sufficient data on this challenging diagnosis, it is known 
that it could be misdiagnosed with inflammatory breast carcinoma. A crucial part of the proper histo-
pathologic diagnosis is immunohistochemistry. Different modalities of treatment include operative 
procedure, chemotherapy and radiotherapy. Recent studies suggest chemotherapy and radiotherapy to 
be initial treatment for patients with primary breast lymphomas.
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Introduction
Breast lymphoma is a rare condition, both as pri-
mary and metastatic disease. The primary form has an 
incidence ranging from 0.04% to 0.5% of all breast 
neoplasms, whereas the metastatic form has an inci-
dence of approximately 0.07%. Primary breast lym-
phoma accounts for 0.04%-0.5% of all breast malig-
nancies1,2. Primary non-Hodgkin’s lymphomas (NHL) 
of the breast are extremely rare and represent 0.38%-
0.7% of all cases3. Epstein-Barr virus (EBV) has been 
postulated to play an important role in the pathogen-
esis of classical Hodgkin’s lymphoma. We present a 
case of EBV-positive primary Hodgkin’s lymphoma.
Case Report
A 66-year-old patient, para III, presented with 2 
fast-growing solid, painless lumps in the upper right 
quadrant towards the axilla. Clinical examination re-
vealed regularly shaped, mobile, painless lumps, with-
out any significant changes on the skin. Ultrasono-
graphic examination showed a homogeneous tumor 
within the axillary fossa that spread towards the right 
breast, measuring 8x8 cm in diameter. All laboratory 
tests and tumor markers were within the normal range. 
Magnetic resonance imaging (MRI) of the abdomen 
and thorax did not reveal any primary or metastatic 
disease. The patient underwent total excision of the 
breast tumor and axillary dissection. Operative proce-
dure and postoperative course were uneventful. A 
semi-solid tumor of 114 g within fatty tissue was extir-
pated and measured 10x7x4 cm (Fig. 1). Histopatho-
logic examination showed disruption of lymphatic ar-
chitecture with fibrosis within 3 out of 8 lymph nodes, 
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surrounded by eosinophilic infiltration, interfollicular 
atypical blasts, lymphomatous infiltration and histio-
cytes. Large multinuclear tumor cells with prominent 
nuclei and Reed-Sternberg cells were identified.
Blastoid cells were CD30 positive showing immu-
nohistochemistry coexpression with CD15, LCA 
(CD45) and were CD20 negative, with CD3 positive 
T-lymphocytes. Five of 8 lymph nodes were without 
metastatic tumor tissue. The histopathology finding 
was suggestive of classical EBV-positive Hodgkin’s 
lymphoma of mixed type. The patient was referred for 
further hemato-oncologic treatment.
Discussion
According to the literature, there are no sufficient 
data on malignant lymphoma of the breast. They may 
present both as a primary or secondary tumor, and 
both are rare. There are no morphological criteria to 
differentiate between the two4. Although primary 
breast lymphoma may appear at any age, the majority 
of patients are postmenopausal women5.
Liu et al.1 have published data on 93 patients with 
primary breast lymphoma; according to Ann Arbor 
classification, 57% of patients were stage I, 23% were 
stage II, 4% stage III and 16% stage IV. With 3-year 
survival, overall survival rate of 70% and high relapse 
rate of 48%, it is considered to be a reason for concern. 
The patients having received chemotherapy and radio-
therapy had better survival rate and lower relapse rate; 
therefore, the authors suggest that chemotherapy and 
radiotherapy be the initial treatment for patients with 
primary breast lymphoma. Zarnescu et al.5 have pub-
lished a case report about unusual presentation of pri-
mary Hodgin’s lymphoma of the breast. The tumor 
clinically presented as inflammatory breast cancer and 
core biopsy showed granulomatous mastitis, requiring 
surgical biopsy. This case showed that despite the un-
common clinical presentation, step-by-step diagnosis 
led to immunohistochemistry and proper diagnosis. 
Some recent studies have shown that primary non-
Hodgkin’s lymphoma of the breast involving the axilla 
usually presents with the clinical appearance of in-
flammatory breast carcinoma without infiltration of 
the breast dermal lymphatics6. Tumor growth is usu-
ally accelerated7, which leads to enlarged tumors like 
the one described by Rahmat et al.8. EBV has been 
postulated to play an important role in the pathogen-
esis of Hodgkin’s lymphoma. It is important to men-
tion that immunodeficiency status such as HIV infec-
tion may predispose to EBV-associated Hodgkin’s 
lymphoma9.
The aim of this case report is to highlight an un-
common oncologic disorder such as primary Hodg-
kin’s lymphoma of the breast and particularly to em-
phasize its clinical, radiological and histopathologic 
presentations, and to discuss all the possible modalities 
of treatment (surgery, chemotherapy, radiotherapy).
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Sažetak
PRIMARNI HODGKINOV LIMFOM DOJKE INICIJALNO LIJEČEN  
KIRURŠKOM EKSCIZIJOM I AKSILARNOM DISEKCIJOM
I. Marton, Z. Hrgović i D. Habek
Incidencija primarnih limfoma dojke kreće se od 0,04% do 0,5%. Primarni non-Hodgkinov limfom dojke iznimno je 
rijedak s učestalošću od oko 0,38%-0,7%. Dokazano je kako u patogenezi Hodgkinova limfoma sudjeluje Epstein-Barrov 
virus (EBV). Prikazujemo slučaj bolesnice s EBV-pozitivnim primarnim Hodgkinovim limfomom dojke. Iako do danas 
nema dovoljno literaturnih podataka o ovoj iznimno intrigantnoj bolesti, poznato je da je u najvećem broju slučajeva naj-
ozbiljniji diferencijalno dijagnostički problem upalni karcinom dojke. Temeljna odrednica histološke dijagnostike je imuno-
histokemija. Postoje različiti modaliteti liječenja koji uključuju operacijski zahvat te kemoterapiju i radioterapiju. Novije 
studije preporučuju kombinaciju kemoiradijacijskog liječenja kao inicijalnog tretmana primarnog limfoma dojke.
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